Gilead Sciences, Inc. (GILD) vs Pfizer Inc. (PFE)
A side-by-side comparison of Gilead Sciences, Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
GILD
Gilead Sciences, Inc.
$134.32HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
PFE
Pfizer Inc.
$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT
Total return — GILD vs PFE
growth of $100 · dividends reinvested · last 30yGILD +33159.4%PFE +562.5%GILD compounded faster
Log scale — wide-divergence pair
GILD PFE
GILD vs PFE: by the numbers
- •GILD is the larger company ($166.77B vs $143.91B market cap).
- •GILD trades at the lower trailing earnings multiple (17.78 vs 18.83 P/E), one valuation lens rather than an overall verdict.
- •GILD converts more revenue to profit (30.99% vs 11.83% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 3.07% CAGR).
- •PFE pays the higher dividend yield (6.97% vs 2.47%).
Metrics side by side
Valuation
| Metric | GILD | PFE |
|---|---|---|
| P/E ratio | 17.78 | 18.83 |
| Forward P/E | N/A | 8.38 |
| P/S ratio | 5.50 | 2.23 |
| P/B ratio | 6.96 | 1.57 |
| PEG ratio | 0.01 | N/A |
| EV / EBITDA | 12.61 | 9.72 |
| FCF yield | 6.25% | 6.71% |
Profitability
| Metric | GILD | PFE |
|---|---|---|
| Gross margin | 79.35% | 69.35% |
| Operating margin | 38.26% | 23.45% |
| Net margin | 30.99% | 11.83% |
| ROE | 39.19% | 8.31% |
| ROIC | 21.53% | 8.84% |
Dividends
| Metric | GILD | PFE |
|---|---|---|
| Dividend yield | 2.47% | 6.97% |
| Payout ratio | 47.08% | 126.47% |
Growth (annualized)
| Metric | GILD | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 3.07% | 8.22% |
| EPS CAGR (5Y) | 133.83% | -3.78% |
| FCF CAGR (5Y) | 3.30% | -3.79% |
| Total return CAGR (5Y) | 18.02% | -5.21% |
Frequently asked
- Which has the lower trailing P/E, GILD or PFE?
- GILD has the lower trailing P/E: GILD trades at 17.78 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, GILD or PFE?
- Over the past five years, PFE grew revenue faster — GILD at a 3.07% CAGR versus PFE at 8.22%.
- Does GILD or PFE pay a bigger dividend?
- GILD yields 2.47% and PFE yields 6.97% based on trailing dividends and the latest price.
- Is GILD or PFE more profitable?
- GILD runs the higher net margin — GILD at 30.99% versus PFE at 11.83%.
- How have GILD and PFE total returns compared?
- Over the past 10 years, GILD delivered 8.90% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Gilead Sciences P/E ratioPfizer P/E ratioGilead Sciences dividend yieldPfizer dividend yieldGilead Sciences ROEPfizer ROEGilead Sciences operating marginPfizer operating marginGilead Sciences revenue growthPfizer revenue growthGilead Sciences free cash flowPfizer free cash flow
Gilead Sciences & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.